2013
DOI: 10.3844/ajptsp.2013.148.154
|View full text |Cite
|
Sign up to set email alerts
|

Toxicity of Zinc Oxide Nanoparticles in Lung Tissue After Repeated Oral Administration

Abstract: Pathological experiments should be considered following oral administration of ZnO. Effect of different doses of ZnO nanoparticle on LDH in oral method showed significant differences in control group (p<0.05) at high dose. Levels of IgG, TNF-α and IL-6 also elevated after administration of ZnO. The level of GSH decreased significantly. Lung damages included hyperemia and bleeding, atelectasis, light emphysema, pribronchiolitis, perivasculitis of lymphocyte in intensive level, pneumonia and increased secretion … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1

Citation Types

2
5
0

Year Published

2015
2015
2020
2020

Publication Types

Select...
5
1

Relationship

0
6

Authors

Journals

citations
Cited by 9 publications
(7 citation statements)
references
References 22 publications
2
5
0
Order By: Relevance
“…Shearing of DNA of splenocytes and thymocytes was noted. Similar data in rat lung after oral administration of ZnO NPs were reported . In the same line, the study of Tian et al revealed elevations of proinflammatory cytokines in the serum and the brain of mice after intraperitoneal injection of ZnO NPs.…”
Section: Discussionsupporting
confidence: 78%
“…Shearing of DNA of splenocytes and thymocytes was noted. Similar data in rat lung after oral administration of ZnO NPs were reported . In the same line, the study of Tian et al revealed elevations of proinflammatory cytokines in the serum and the brain of mice after intraperitoneal injection of ZnO NPs.…”
Section: Discussionsupporting
confidence: 78%
“…9 ). GSH levels have been reported to be decreased significantly after oral administration of ZnO NPs in lung tissue [55] . In the present study, the ZnO NPs showed an insignificant difference in GSH activity compared to their ionic forms.…”
Section: Discussionmentioning
confidence: 99%
“…Group 2 (querectin-treated group) rats received 100 mg/kg body weight querectin orally once daily for 12 weeks dissolved in distilled water, and this oral protective dose of querectin has been reported previously as a good protective daily dose in rats [15]. Group 3 (low ZnO-treated group) rats received 100 mg/kg body weight ZnO per day for 12 weeks orally dissolved in distilled water, meanwhile group 4 rats received high ZnO-treated group (400 mg/kg body weight) once daily for 12 weeks [16,17]. Group 5 rats were treated with querectin and low ZnO dose as in groups and 3, whereas group 6 rats were treated with querectin and high ZnO dose as in groups 2 and 4.…”
Section: Experimental Designmentioning
confidence: 99%